These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31002356)

  • 21. ADAMTSL5 and CDH11: putative epigenetic markers for therapeutic resistance in acute lymphoblastic leukemia.
    Abdullah M; Choo CW; Alias H; Abdul Rahman EJ; Mohd Ibrahim H; Jamal R; Hussin NH
    Hematology; 2017 Aug; 22(7):386-391. PubMed ID: 28292214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypermethylation of CpG island in the promoter region of CALCA in acute lymphoblastic leukemia with central nervous system (CNS) infiltration correlates with poorer prognosis.
    Paixão VA; Vidal DO; Caballero OL; Vettore AL; Tone LG; Ribeiro KB; Lopes LF
    Leuk Res; 2006 Jul; 30(7):891-4. PubMed ID: 16712930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TET2 Promoter DNA Methylation and Expression in Childhood Acute Lymphoblastic Leukemia.
    Bahari G; Hashemi M; Naderi M; Taheri M
    Asian Pac J Cancer Prev; 2016; 17(8):3959-62. PubMed ID: 27644645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. History of Parvovirus B19 infection is associated with a DNA methylation signature in childhood acute lymphoblastic leukemia.
    Vasconcelos GM; Christensen BC; Houseman EA; Xiao J; Marsit CJ; Wiencke JK; Zheng S; Karagas MR; Nelson HH; Wrensch MR; Kelsey KT; Pombo-de-Oliveira MS; Wiemels JL
    Epigenetics; 2011 Dec; 6(12):1436-43. PubMed ID: 22139573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Quantitative microarray-based DNA methylation analysis of E-cadherin gene promoter in acute leukemia].
    Chen BA; Zhang F; Wang Y; Zheng WL; Du J; Gao C; Ding JH; Sun YY; Cheng J; Wang J; Zhao G; Chen NN; Lu ZH
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):41-4. PubMed ID: 17575692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [LRP15 gene promoter region methylation and its expression in acute leukemia].
    Zhao Y; Dou LP; Wang QS; Lu XC; Lou FD; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):39-41. PubMed ID: 17490517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant DNA methylation of key genes and Acute Lymphoblastic Leukemia.
    Rahmani M; Talebi M; Hagh MF; Feizi AAH; Solali S
    Biomed Pharmacother; 2018 Jan; 97():1493-1500. PubMed ID: 29793312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic variants of methyl metabolizing enzymes and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancer.
    de Vogel S; Wouters KA; Gottschalk RW; van Schooten FJ; de Goeij AF; de Bruïne AP; Goldbohm RA; van den Brandt PA; Weijenberg MP; van Engeland M
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3086-96. PubMed ID: 19843671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA methylation of multiple promoter-associated CpG islands in adult acute lymphocytic leukemia.
    Garcia-Manero G; Daniel J; Smith TL; Kornblau SM; Lee MS; Kantarjian HM; Issa JP
    Clin Cancer Res; 2002 Jul; 8(7):2217-24. PubMed ID: 12114423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant promoter hypermethylation of selected apoptotic genes in childhood acute lymphoblastic leukemia among North Indian population.
    Nikbakht M; Jha AK; Malekzadeh K; Askari M; Mohammadi S; Marwaha RK; Kaul D; Kaur J
    Exp Oncol; 2017 Mar; 39(1):57-64. PubMed ID: 28361856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant methylation in promoter-associated CpG islands of multiple genes in acute lymphoblastic leukemia.
    Yang Y; Takeuchi S; Hofmann WK; Ikezoe T; van Dongen JJ; Szczepański T; Bartram CR; Yoshino N; Taguchi H; Koeffler HP
    Leuk Res; 2006 Jan; 30(1):98-102. PubMed ID: 16039715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypermethylation of CpG islands in the promoter region of the p15INK4B gene in childhood acute leukaemia.
    Tsellou E; Troungos C; Moschovi M; Athanasiadou-Piperopoulou F; Polychronopoulou S; Kosmidis H; Kalmanti M; Hatzakis A; Dessypris N; Kalofoutis A; Petridou E
    Eur J Cancer; 2005 Mar; 41(4):584-9. PubMed ID: 15737564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia.
    Tao YF; Fang F; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Li ZH; Wang NN; Xu LX; Du XJ; Sun LC; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
    BMC Cancer; 2015 Oct; 15():756. PubMed ID: 26490736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression and Promoter CpG Island Methylation Status of miR-34b in Leukemia Cell Lines and Their Clinical Significance].
    Guo JX; Zhou YH; Guan RT; Pan JX; Zhang XY; Zhong JF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1235-9. PubMed ID: 26524015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
    Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
    J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemia.
    Milani L; Lundmark A; Kiialainen A; Nordlund J; Flaegstad T; Forestier E; Heyman M; Jonmundsson G; Kanerva J; Schmiegelow K; Söderhäll S; Gustafsson MG; Lönnerholm G; Syvänen AC
    Blood; 2010 Feb; 115(6):1214-25. PubMed ID: 19965625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic changes in the DAP-kinase CpG island in pediatric lymphoma.
    Shiramizu B; Mick P
    Med Pediatr Oncol; 2003 Dec; 41(6):527-31. PubMed ID: 14595709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) gene polymorphisms as risk factors for hepatocellular carcinoma in a Korean population.
    Kwak SY; Kim UK; Cho HJ; Lee HK; Kim HJ; Kim NK; Hwang SG
    Anticancer Res; 2008; 28(5A):2807-11. PubMed ID: 19035314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alteration in the expression of MGMT and RUNX3 due to non-CpG promoter methylation and their correlation with different risk factors in esophageal cancer patients.
    Saikia S; Rehman AU; Barooah P; Sarmah P; Bhattacharyya M; Deka M; Deka M; Goswami B; Husain SA; Medhi S
    Tumour Biol; 2017 May; 39(5):1010428317701630. PubMed ID: 28468586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.